UNITEDHEALTH GROUP INCORPORATED (Delaware) UNH

UnitedHealth Group Incorporated es una empresa diversificada de atención médica. La Compañía opera a través de cuatro segmentos: UnitedHealthcare, OptumHealth, OptumInsight y OptumRx. Lleva a cabo sus operaciones a través de dos plataformas comerciales: beneficios de salud operando bajo UnitedHealthcare y servicios de salud operando bajo Optum. UnitedHealthcare ofrece atención médica que incluye UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State y UnitedHealthcare Global. Optum sirve al mercado de la atención médica, incluidos pagadores, proveedores de atención, empleadores, gobiernos, empresas de ciencias de la vida y consumidores, a través de sus negocios OptumHealth, OptumInsight y OptumRx. OptumHealth se enfoca en la prestación de atención, gestión de la atención, bienestar y participación del consumidor, y servicios financieros de salud. OptumInsight ofrece datos, análisis, investigación, consultoría, tecnología y soluciones de servicios gestionados. OptumRx ofrece una variedad de servicios de atención farmacéutica.

Con 3 acciones de UNH (USD 1.132,95) habrías recibido USD 27,18 en dividendos en los últimos 12 meses.

UNH hizo una división de acciones (split) de 2:1 el 31 de mayo de 2005: cada acción se convirtió en 2. Cambió la cantidad de acciones y su precio, pero no el valor total de la inversión.

• The Motley Fool 3 oct

  UnitedHealth Reports on Oct. 13. Here's the 1 Number I'm Watching.

  UnitedHealth Group will report Q3 earnings on October 13. The key metric to watch is the medical care ratio (MCR), which measures the percentage of insurance premiums paid out for claims. A lower MCR improves profitability. UnitedHealth successfully reduced its MCR to 86.7% in Q2 from 89.4% a year earlier, driven by benefit design, pricing discipline, and member mix adjustments. Investors will closely monitor whether the company can maintain or further reduce this critical ratio.

  

• Zacks Investment Research 2 oct

  UnitedHealth Group (UNH) Surpasses Market Returns: Some Facts Worth Knowing

  UnitedHealth Group closed at $371.90, up 1.83% and outperforming the S&P 500's 0.73% gain. The stock is rated Zacks Rank #2 (Buy) with an upcoming earnings report on October 13, 2026, expected to show 41.1% EPS growth. UNH trades at a Forward P/E of 18.4, below the industry average of 21.25, and is positioned in the top 9% of industries.

  

• The Motley Fool 30 sept

  Warren Buffett's Record: $1,000 Became About $61 Million. Can Greg Abel Keep Compounding It?

  Warren Buffett stepped down as Berkshire Hathaway chairman in September 2026, ending an era of exceptional returns (6,099,294% since 1965). New CEO Greg Abel faces the challenge of maintaining growth, but Berkshire's massive $1.1 trillion size makes repeating historical 19.7% annual returns virtually impossible. The company has underperformed the S&P 500 over the past decade and is sitting on $365.6 billion in cash while making strategic portfolio shifts.

  

• GlobeNewswire Inc. 30 sept

  Hatteras Venture Partners Names Sir Andrew Witty as Chairman and Ned Sharpless, M.D., as Managing Director of Hatteras Discovery Innovation, Expanding Proven Investment Strategies

  Hatteras Venture Partners appointed Sir Andrew Witty as Chairman and Dr. Ned Sharpless as Managing Director of Hatteras Discovery Innovation. The firm announced the first closing of Hatteras Opportunity Fund II targeting $100 million, bringing total capital under management to over $1 billion. The new Discovery strategy aims to replicate the success of the original 2012 initiative that seeded 11 companies and contributed to two FDA-approved medicines.

  

• GlobeNewswire Inc. 24 sept

  Reuters Momentum AI Austin Day 1: A New Way to Measure Whether AI Is Actually Paying Off

  Enterprise AI is shifting from experimentation to demonstrating measurable ROI. Companies like FedEx ($3B in cost reductions), Mars (20% top-line growth), and Indeed (70% of matches from AI) are scaling AI beyond pilots, but success requires organizational redesign, clear ownership, and human oversight. Leaders warn that AI can amplify existing organizational weaknesses and autonomous agents need defined spending limits and accountability measures.